| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/09/2006 | WO2006026447A2 PRODUCTION OF TNFR-Ig FUSION PROTEIN |
| 03/09/2006 | WO2006026331A2 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/09/2006 | WO2006026238A2 Rna interference in avians |
| 03/09/2006 | WO2006026125A2 Improved strains of e. coli for plasmid dna production |
| 03/09/2006 | WO2006025802A1 Method for maintaining pluripotency of stem/progenitor cells |
| 03/09/2006 | WO2006025580A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 03/09/2006 | WO2006025526A1 Process for producing dendritic cell having acquired ctl inducing capability |
| 03/09/2006 | WO2006025525A1 Method of selecting protein easily undergoing antigen-presentation by dendritic cells |
| 03/09/2006 | WO2006025477A1 Industrially useful microorganism |
| 03/09/2006 | WO2006025443A1 Genetically modified plant proudcing lactosyl ceramide and utilization of the same |
| 03/09/2006 | WO2006025425A1 Protein participating in inhibition of plasmodium growth |
| 03/09/2006 | WO2006025419A1 Conjugate of peo with double-stranded nucleic acid |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006025295A1 Yeast strain releasing mannan protein and method of producing mannan protein |
| 03/09/2006 | WO2006025074A2 Twodimensional strandness- and length-dependent separation of nucleic acid fragments |
| 03/09/2006 | WO2006024880A2 Methods and compositions to inhibit p2x7 receptor expression |
| 03/09/2006 | WO2006024875A2 Method for determinig protein solubility |
| 03/09/2006 | WO2006024867A2 Method for improved transgene expression |
| 03/09/2006 | WO2006024547A2 Protease resistant human and non-human hmgb1 box-a mutants and their therapeutic/diagnostic use |
| 03/09/2006 | WO2006024533A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | WO2006024509A2 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 03/09/2006 | WO2006024351A1 Herbicide-resistant sunflower plants, plynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins, and methods of use |
| 03/09/2006 | WO2006002627A9 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 03/09/2006 | WO2005118822A3 Generation of plants with altered oil content |
| 03/09/2006 | WO2005118814A3 Metabolically engineered cells for the production of polyunsaturated fatty acids |
| 03/09/2006 | WO2005118644A3 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2006 | WO2005115358A3 Intranasal delivery of nucleic acid molecules |
| 03/09/2006 | WO2005113813A8 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics |
| 03/09/2006 | WO2005104823A8 Shade responsive promoter, promoter control elements, and combinations and uses thereof |
| 03/09/2006 | WO2005103239A3 Novel alcohol dehydrogenases |
| 03/09/2006 | WO2005100609A3 Methods for identifying genes that mediate a response of a living cell to an agent |
| 03/09/2006 | WO2005090566A3 Ligational encoding using building block oligonucleotides |
| 03/09/2006 | WO2005083095A3 Methods for enhancing insect resistance in plants |
| 03/09/2006 | WO2005079183A3 Method for production of c30-aldehyde carotenoids |
| 03/09/2006 | WO2005077976A3 Coiled-coil domains from c4b-binding protein |
| 03/09/2006 | WO2005073243A3 Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | WO2005060664A3 Stress tolerant plants and methods thereof |
| 03/09/2006 | WO2005056830A3 Genetic reference materials |
| 03/09/2006 | WO2005052133A3 Method and markers for determining the genotype of horned/polled cattle |
| 03/09/2006 | WO2004028471A3 Influenza therapeutic |
| 03/09/2006 | WO2003066879A3 Amino acid transporters |
| 03/09/2006 | US20060053516 Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 03/09/2006 | US20060053515 Using transgenic plants as bioreactors for synthesis of hemoglobin |
| 03/09/2006 | US20060053513 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 03/09/2006 | US20060053512 Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof |
| 03/09/2006 | US20060053510 Transgenic plants incorporating traits of Zostera marina |
| 03/09/2006 | US20060053509 Germ-responsive promoter |
| 03/09/2006 | US20060053508 Cotton Cultivar 05X494BR |
| 03/09/2006 | US20060053507 Regulatory sequence |
| 03/09/2006 | US20060053505 Bioluminescent novelty items |
| 03/09/2006 | US20060053504 Tissue specific expression of exogenous proteins in transgenic chickens |
| 03/09/2006 | US20060053499 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052584 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 03/09/2006 | US20060052580 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/09/2006 | US20060052335 Chondroitin synthetase and dna encoding the enzyme |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052325 Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution |
| 03/09/2006 | US20060052324 Methods and compositions for cell activation |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052322 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 03/09/2006 | US20060052320 Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes |
| 03/09/2006 | US20060052319 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 03/09/2006 | US20060052317 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060051878 Nano-sized optical fluorescence labels and uses thereof |
| 03/09/2006 | US20060051870 Methods and compositions for the introduction of molecules into cells |
| 03/09/2006 | US20060051869 Transport proteins and their uses |
| 03/09/2006 | US20060051866 Means of producing and utilising a population of disease specific cytotoxic t-lymphocytes |
| 03/09/2006 | US20060051859 Long acting human interferon analogs |
| 03/09/2006 | US20060051853 Human MEKK proteins, corresponding nucleic acid molecules and uses therefor |
| 03/09/2006 | US20060051851 Novel selenocysteine-containing protein |
| 03/09/2006 | US20060051850 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/09/2006 | US20060051849 Thermostable alpha-amylases |
| 03/09/2006 | US20060051847 Metabolically engineered cells for the production of polyunsaturated fatty acids |
| 03/09/2006 | US20060051843 Fluorescent protein for use as resolution tools in genetic analysis |
| 03/09/2006 | US20060051842 Nucleic acid encoding alpha chain of human IL-11 receptor |
| 03/09/2006 | US20060051840 Hybrid expression of neisserial proteins |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051838 Genetic computing using combinatorial transcription control |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051834 Method for preparative in vitro protein biosynthesis |
| 03/09/2006 | US20060051832 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 03/09/2006 | US20060051822 Methods for detecting Bacillus thuringiensis cryET33 and cry ET34 polypeptides |
| 03/09/2006 | US20060051809 Detection of nucleic acids by target-specific hybrid capture method |
| 03/09/2006 | US20060051806 Diagnosing blood disorder via presence of missense mutation in hemochromatosis gene |
| 03/09/2006 | US20060051804 Oligonucleotides labeled with stable isotopes and a method for detecting the same |
| 03/09/2006 | US20060051795 Oligonucleotide mediated nucleic acid recombination |
| 03/09/2006 | US20060051791 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051782 as biocatalysts in industrial chemical redox reactions, such as the oxidation of aromatic hydrocarbons, for example, toluene, benzene, or nitrobenzene, into industrially desirable products |